UBQLN4 Gene

UBQLN4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UBQLN4 — Ubiquilin 4</th>
</tr>
<tr> [@vcpubiquilin2018]
<td class="label">Symbol</td> [@neuronal2019]
<td><strong>UBQLN4</strong></td> [@proteasome2017]
</tr> [@autophagy2020]
<tr> [@vcp2018]
<td class="label">Full Name</td> [@ubqln2020]
<td>Ubiquilin 4</td> [@ubqln2020a]
</tr> [@nuclear2021]
<tr> [@tdp2019]
<td class="label">Chromosome</td> [@recessive2018]
<td>Xq24</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/94160" target="_blank">94160</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163527" target="_blank">ENSG00000163527</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/300368" target="_blank">300368</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5X5" target="_blank">Q9Y5X5</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[ALS](/diseases/als), FTD</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Motor cortex, Hippocampus, Cerebellum</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">P497S, T187fs, R198X</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

UBQLN4 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UBQLN4 — Ubiquilin 4</th>
</tr>
<tr> [@vcpubiquilin2018]
<td class="label">Symbol</td> [@neuronal2019]
<td><strong>UBQLN4</strong></td> [@proteasome2017]
</tr> [@autophagy2020]
<tr> [@vcp2018]
<td class="label">Full Name</td> [@ubqln2020]
<td>Ubiquilin 4</td> [@ubqln2020a]
</tr> [@nuclear2021]
<tr> [@tdp2019]
<td class="label">Chromosome</td> [@recessive2018]
<td>Xq24</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/94160" target="_blank">94160</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163527" target="_blank">ENSG00000163527</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/300368" target="_blank">300368</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q9Y5X5" target="_blank">Q9Y5X5</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[ALS](/diseases/als), FTD</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Motor cortex, Hippocampus, Cerebellum</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">P497S, T187fs, R198X</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

UBQLN4 — Ubiquilin 4

Introduction

UBQLN4 (Ubiquilin 4) is a gene located on chromosome Xq24 that encodes a member of the ubiquilin family of proteins involved in protein quality control and degradation pathways. Mutations in UBQLN4 have been increasingly recognized as important contributors to neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). This gene encodes a protein that plays critical roles in targeting misfolded proteins for proteasomal and autophagic degradation, making it essential for maintaining neuronal proteostasis.

The ubiquilin family (UBQLN1, UBQLN2, UBQLN3, UBQLN4, and UBQLNL in humans) shares a common architecture featuring an N-terminal ubiquitin-like (Ubl) domain and a C-terminal ubiquitin-associated (UBA) domain, connected by a variable middle region containing multiple stiff-chain (STI) motifs. UBQLN4, also known as UBIN or GIDE, is particularly enriched in the brain and has been implicated in both autosomal dominant and recessive forms of neurodegeneration^[1].

Overview

UBQLN4 is a 624-amino acid protein that serves as a molecular adaptor linking ubiquitinated proteins to the proteasome and autophagy machinery. The gene is catalogued as NCBI Gene ID 94160 and OMIM 300368. UBQLN4 is expressed throughout the brain with high expression in motor cortex, hippocampus, and cerebellum — regions prominently affected in ALS and FTD^[2]. The protein localizes to the cytoplasm and nucleus, where it participates in various protein quality control pathways. Dysfunction of UBQLN4 leads to accumulation of ubiquitinated protein aggregates, a hallmark pathology observed in most neurodegenerative diseases.

Protein Structure and Domains

The UBQLN4 protein contains several functionally important domains:

N-Terminal Ubiquitin-Like (Ubl) Domain (aa 1-70)

The N-terminal Ubl domain adopts a β-grasp fold similar to ubiquitin and is involved in binding to proteasome subunits. This domain facilitates the delivery of ubiquitinated substrates to the 26S proteasome for degradation. The Ubl domain also interacts with autophagy receptors, enabling selective autophagy pathways^[3].

STI1 Domains (aa 150-550)

The middle region of UBQLN4 contains multiple STI1 (Stress-Induced Phosphoprotein 1) repeat motifs. These coiled-coil domains mediate protein-protein interactions and are crucial for forming homomeric and heteromeric complexes with other ubiquilin family members. The STI1 domains also interact with various client proteins, including RNA-binding proteins and mitochondrial proteins^[4].

C-Terminal Ubiquitin-Associated (UBA) Domain (aa 560-620)

The C-terminal UBA domain binds monoubiquitin and polyubiquitin chains of various linkages. This domain recognizes ubiquitinated substrates and targets them for degradation. The UBA domain also interacts with valosin-containing protein (VCP/p97), an AAA+ ATPase involved in extracting ubiquitinated proteins from membranes and protein complexes for proteasomal degradation^[5].

Molecular Function

Protein Quality Control

UBQLN4 plays a central role in the cellular protein quality control network. As a ubiquitin-binding adaptor protein, it recognizes misfolded or damaged proteins that have been tagged with ubiquitin chains. UBQLN4 then facilitates the delivery of these substrates to either the 26S proteasome for degradation or to autophagy receptors for lysosomal degradation. This function is particularly important in [neurons](/entities/neurons), which are long-lived cells with limited regenerative capacity^[6].

Proteasome Targeting

Through its Ubl domain, UBQLN4 binds to the 19S regulatory particle of the 26S proteasome. This interaction delivers ubiquitinated substrates to the proteasome for unfolding and degradation. UBQLN4 can also shield substrates from deubiquitinating enzymes, preserving the ubiquitin signal for proteasomal recognition^[7].

Autophagy Regulation

UBQLN4 interacts with autophagy receptors such as p62/SQSTM1 and OPTN through its UBA domain. These interactions link UBQLN4 to selective autophagy pathways including mitophagy (mitochondrial autophagy), aggrephagy (aggregate autophagy), and ribophagy. UBQLN4 can be itself degraded by autophagy, suggesting a role in autophagic flux regulation^[8].

VCP/p97 Complex Formation

The interaction between UBQLN4 and VCP/p97 is critical for extracting ubiquitinated proteins from membranes, protein complexes, and chromatin. This extraction process, also known as ubiquitination-dependent protein extraction (UDPE), is essential for protein turnover, DNA repair, and stress response. Mutations affecting VCP cause inclusion body myopathy with early-onset Paget disease of bone and frontotemporal dementia (IBMPFD), highlighting the importance of this pathway in neurodegeneration^[9].

Brain Expression and Cellular Localization

Regional Expression

UBQLN4 is widely expressed throughout the human brain with particularly high levels in:

• Motor [Cortex](/brain-regions/cortex): The primary site of upper motor neuron cell bodies, highly relevant to ALS pathogenesis
• [Hippocampus](/brain-regions/hippocampus): Critical for memory formation and affected early in both AD and FTD
• Cerebellum: Involved in motor coordination and also affected in various ataxias and ALS
• Basal Ganglia: Contains neurons vulnerable in Parkinson's disease and related disorders
• Spinal Cord: Contains lower motor neurons that degenerate in ALS

Subcellular Localization

Within neurons, UBQLN4 localizes to:

• Cytoplasm: Diffuse cytoplasmic distribution with enrichment at dendritic branch points
• Nucleus: Nuclear localization suggests additional roles in transcriptional regulation
• Mitochondria: Partial mitochondrial association relevant to mitophagy regulation
• Synapses: Presence at synaptic terminals indicates roles in synaptic protein quality control

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

UBQLN4 mutations were first linked to ALS in 2018 when dominant missense and frameshift mutations were identified in familial ALS patients. The P497S mutation, located in the STI1 domain, is the most frequently reported pathogenic variant^[11].

Disease Mechanisms:

• Impaired proteasome function: Mutant UBQLN4 interferes with proteasomal targeting, leading to accumulation of ubiquitinated proteins
• Altered autophagy: Dysregulated selective autophagy results in protein aggregate formation
• Mitochondrial dysfunction: Impaired mitophagy leads to accumulation of damaged mitochondria
• Stress granule dynamics: UBQLN4 localizes to stress granules; mutations affect RNA granule clearance
• Nuclear import defects: Some mutations disrupt nuclear-cytoplasmic transport, a pathway increasingly implicated in ALS^[12]

Frontotemporal Dementia (FTD)

UBQLN4 mutations also cause FTD, particularly the behavioral variant (bvFTD). The disease mechanisms overlap substantially with ALS, reflecting the clinicopathological continuum between these disorders.

Pathological Features:

• [TDP-43](/proteins/tdp-43) proteinopathy: Ubiquitinated [TDP-43](/mechanisms/tdp-43-proteinopathy) inclusions in affected brain regions
• Motor neuron involvement: Some FTD patients develop ALS symptoms
• Frontal and temporal lobe atrophy on MRI
• Variable involvement of hippocampus and basal ganglia^[13]

Other Neurodegenerative Diseases

While most strongly associated with ALS and FTD, UBQLN4 dysfunction may contribute to:

• Alzheimer's Disease: Impaired proteostasis affects amyloid and [tau](/proteins/tau) clearance
• Parkinson's Disease: Altered mitophagy may affect dopaminergic neuron survival
• Huntington's Disease: Polyglutamine-expanded [huntingtin](/proteins/huntingtin-protein) overwhelm protein quality control

Key Mutations

| Mutation | Type | Domain | Clinical Phenotype |
|----------|------|--------|---------------------|
| P497S | Missense | STI1 | ALS, FTD |
| T187fs | Frameshift | STI1 | ALS (recessive) |
| R198X | Nonsense | STI1 | ALS (recessive) |
| G183R | Missense | STI1 | FTD |
| K207R | Missense | STI1 | ALS |

The P497S mutation is the most studied and affects UBQLN4's ability to interact with VCP and proteasome subunits. Recessive mutations (T187fs, R198X) likely cause disease through loss-of-function mechanisms^[14].

Interaction Network

UBQLN4 interacts with numerous proteins involved in protein quality control and neurodegeneration:

Proteasome Components

• PSMC2, PSMC4, PSMD1 (19S regulatory particles)
• PSMA1-7 (20S core particles)

Autophagy Receptors

• p62/SQSTM1
• OPTN
• NDP52 (CALCOCO2)

AAA+ ATPases

• VCP/p97 (primary interaction)
• p97ND4L

Ubiquitin System

• Various E3 ubiquitin ligases
• UBQLN1, UBQLN2 (other ubiquilins)

Disease-Related Proteins

• TDP-43 (TARDBP)
• FUS
• SOD1
• [C9orf72](/entities/c9orf72) dipeptide repeat proteins

Therapeutic Implications

Small Molecule Approaches

Gene Therapy Strategies

Biomarker Development

• UBQLN4 levels in cerebrospinal fluid as a disease biomarker
• PET tracers targeting UBQLN4 aggregates
• Genetic testing for at-risk individuals

Key Publications

External Links

• NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/94160](https://www.ncbi.nlm.nih.gov/gene/94160)
• Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163527](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163527)
• OMIM: [https://omim.org/entry/300368](https://omim.org/entry/300368)
• UniProt: [https://www.uniprot.org/uniprot/Q9Y5X5](https://www.uniprot.org/uniprot/Q9Y5X5)
• Allen Human Brain Atlas: [UBQLN4 expression](https://human.brain-map.org/microarray/search/show?search_term=UBQLN4)
• ALS Online Genetics Database: [UBQLN4 mutations](https://alsod.ac.uk/)

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)
• [ALS Gene Overview](/diseases/als)
• [FTD Gene Overview](/diseases/frontotemporal-dementia)
• [Protein Quality Control Pathways](/mechanisms/protein-quality-control-network)mechanisms/protein-quality-control-network)
• [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)

Background

The study of Ubqln4 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References